Allan Bayat Selected Research

Tuberous Sclerosis (Bourneville's Disease)

3/2023

Cannabidiol Add-On in Glycosylphosphatidylinositol-Related Drug-Resistant Epilepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Allan Bayat Research Topics

Disease

8	Seizures (Absence Seizure) 12/2023 - 10/2017
7	Epilepsy (Aura) 03/2024 - 01/2017
6	Neurodevelopmental Disorders 11/2023 - 10/2017
4	Intellectual Disability (Idiocy) 01/2023 - 01/2015
3	Brain Diseases (Brain Disorder) 03/2024 - 04/2015
2	Phenylketonurias (Phenylketonuria) 06/2023 - 02/2015
2	Drug Resistant Epilepsy 03/2023 - 01/2022
2	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2023 - 04/2015
2	Pain (Aches) 11/2022 - 06/2013
2	Epileptic Syndromes 08/2022 - 01/2021
2	Fever (Fevers) 03/2022 - 01/2022
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2021 - 01/2020
1	Congenital Disorders of Glycosylation 11/2023
1	Dysbiosis 06/2023
1	Lennox Gastaut Syndrome 03/2023
1	Protein Deficiency 03/2023
1	Tuberous Sclerosis (Bourneville's Disease) 03/2023
1	Stocco dos Santos syndrome 01/2023
1	Stroke (Strokes) 11/2022
1	Infections 08/2022
1	Rare Diseases (Rare Disease) 07/2022
1	Hypoxia (Hypoxemia) 03/2022
1	Hypocalcemia 03/2022
1	Glycosylphosphatidylinositol deficiency 01/2022
1	Neuroblastoma 01/2022
1	3C syndrome 07/2021
1	Microcephaly 01/2021
1	Language Development Disorders (Semantic-Pragmatic Disorder) 01/2021
1	Facies 01/2021
1	Infantile Epileptic-Dyskinetic Encephalopathy 11/2020
1	Infarction (Infarctions) 08/2018
1	Muscle Hypotonia (Hypotonia) 01/2018
1	Hyperphosphatasia with Mental Retardation 01/2018
1	Agenesis of Corpus Callosum 01/2017
1	Nephrolithiasis 01/2015
1	Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome) 01/2015
1	Gout 01/2015
1	Glomerulonephritis 12/2012
1	Hemorrhage 12/2012

Drug/Important Bio-Agent (IBA)

6	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 11/2023 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2017
2	Glutamic Acid (Glutamate)FDA Link 01/2023 - 02/2022
2	EnzymesIBA 01/2018 - 01/2015
1	Cyclic NucleotidesIBA 03/2024
1	Amitriptyline (Elavil)FDA LinkGeneric 12/2023
1	NAD (NADH)IBA 06/2023
1	CreatineIBA 06/2023
1	Tricarboxylic AcidsIBA 06/2023
1	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 06/2023
1	CannabidiolIBA 03/2023
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2023
1	AcidsIBA 01/2023
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2023
1	perampanelIBA 01/2023
1	O-GlcNAc transferaseIBA 01/2023
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2023
1	NucleotidesIBA 01/2023
1	SaltsIBA 11/2022
1	tocilizumab (atlizumab)FDA Link 08/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 08/2022
1	Calcium Carbonate (Limestone)FDA Link 07/2022
1	Antipsychotic Agents (Antipsychotics)IBA 03/2022
1	Carbamazepine (Tegretol)FDA LinkGeneric 02/2022
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 01/2022
1	Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA 01/2022
1	LigandsIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	ChromatinIBA 01/2021
1	phosphatidylinositol glycan-class A proteinIBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 08/2018
1	Alkaline PhosphataseIBA 01/2018
1	Ion Channels (Ion Channel)IBA 10/2017
1	Sodium Channels (Sodium Channel)IBA 04/2015
1	Phenylalanine (L-Phenylalanine)FDA Link 02/2015
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2015
1	Uric Acid (Urate)IBA 01/2015
1	Nitrous Oxide (Laughing Gas)IBA 06/2013
1	AntibodiesIBA 12/2012
1	antiglomerular basement membrane antibodyIBA 12/2012

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2021
1	Toothbrushing 01/2022
1	Precision Medicine 01/2021